Amylyx 制药 AMLX
$29.50 +$1.88 (+6.81%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.16 +2.24%
开盘$27.73
昨收$27.62
当日区间$27.50 – $29.58
成交量1.86M
市值$3.79B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$45.69M-6.6% YoY
净利润-$43.42M-4.8% YoY
摊薄每股收益-$0.39+15.2% YoY
自由现金流-$31.45M-24.5% YoY
经营现金流-$31.42M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-74.7%
资产收益率-66.2%
投入资本回报率-77.5%
流动比率12.12
负债/资产比率9.6%
现金及投资$250.76M
总负债$4.25M
净现金（净负债）$246.51M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $45.69M | $43.78M | $153.29M | $36.61M | $36.03M |
| 销售及管理费用 | $21.93M | $16.17M | $62.89M | $15.39M | $16.17M |
| 研发费用 | $23.77M | $27.61M | $90.40M | $21.21M | $19.86M |
| 营业利润 | -$45.69M | -$43.78M | -$153.29M | -$36.61M | -$36.03M |
| 非经营性利息净收入（支出） | $2.32M | $2.57M | $9.30M | $3.29M | $1.82M |
| 非经营性利息收入 | $2.32M | $2.57M | $9.30M | $3.29M | $1.82M |
| 其他收入（支出） | -$53,000.00 | -$75,000.00 | -$700,000.00 | $362,000.00 | -$180,000.00 |
| 其他非经营性收入（支出） | -$53,000.00 | -$75,000.00 | -$700,000.00 | $362,000.00 | -$180,000.00 |
| 税前利润 | -$43.42M | -$41.28M | -$144.69M | -$32.95M | -$34.39M |
| 净利润 | -$43.42M | -$41.28M | -$144.74M | -$33.00M | -$34.39M |
| 持续经营利润 | -$43.42M | -$41.28M | -$144.74M | -$33.00M | -$34.39M |
| 归属母公司净利润 | -$43.42M | -$41.28M | -$144.74M | -$33.00M | -$34.39M |
| 归属普通股股东净利润 | -$43.42M | -$41.28M | -$144.74M | -$33.00M | -$34.39M |
| 基本每股收益 | -$0.39 | -$0.37 | -$1.53 | -$0.30 | -$0.37 |
| 摊薄每股收益 | -$0.39 | -$0.37 | -$1.53 | -$0.30 | -$0.37 |
| 报告营业总收入 | – | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业成本 | – | $0.00 | $0.00 | $0.00 | $0.00 |
| 毛利润 | – | $0.00 | $0.00 | $0.00 | $0.00 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $0.00 | $0.00 | $0.00 |
| 税费 | – | – | $46,000.00 | $46,000.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $264.56M | $293.60M | $332.65M | $332.65M | $362.74M |
| 流动资产合计 | $256.34M | $285.02M | $323.67M | $323.67M | $353.38M |
| 现金及现金等价物与短期投资 | $250.76M | $279.77M | $316.98M | $316.98M | $343.99M |
| -现金及现金等价物 | $49.33M | $229.14M | $226.65M | $226.65M | $225.18M |
| -短期投资 | $201.43M | $50.63M | $90.33M | $90.33M | $118.81M |
| 其他流动资产 | $5.58M | $5.26M | $6.60M | $6.60M | $9.26M |
| 非流动资产合计 | $8.23M | $8.58M | $8.97M | $8.97M | $9.36M |
| 固定资产净值 | $4.74M | $5.09M | $5.49M | $5.49M | $5.88M |
| -固定资产原值 | $4.74M | $5.09M | $7.05M | $7.05M | $5.88M |
| 其他非流动资产 | $3.49M | $3.49M | $3.48M | $3.48M | $3.48M |
| 负债合计 | $25.40M | $20.44M | $27.39M | $27.39M | $30.75M |
| 流动负债合计 | $21.15M | $15.97M | $22.69M | $22.69M | $25.79M |
| 应付款 | $5.53M | $3.53M | $3.52M | $3.52M | $5.34M |
| -应付账款 | $5.53M | $3.53M | $3.52M | $3.52M | $5.34M |
| 一年内应计费用 | $8.98M | $8.09M | $7.86M | $7.86M | $9.67M |
| 短期债务及融资租赁负债 | $1.01M | $1.16M | $1.26M | $1.26M | $981,000.00 |
| -一年内到期融资租赁负债 | $1.01M | $1.16M | $1.26M | $1.26M | $981,000.00 |
| 非流动负债合计 | $4.25M | $4.48M | $4.70M | $4.70M | $4.95M |
| 长期债务及融资租赁负债 | $4.25M | $4.48M | $4.70M | $4.70M | $4.95M |
| -长期融资租赁负债 | $4.25M | $4.48M | $4.70M | $4.70M | $4.95M |
| 股东权益合计 | $239.17M | $273.16M | $305.26M | $305.26M | $332.00M |
| 股东权益 | $239.17M | $273.16M | $305.26M | $305.26M | $332.00M |
| 股本 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -普通股 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -优先股 | $0.00 | $0.00 | – | – | $0.00 |
| 资本公积 | $1.08B | $1.07B | $1.06B | $1.06B | $1.05B |
| 留存收益 | -$836.13M | -$792.71M | -$751.43M | -$751.43M | -$718.43M |
| 不影响留存收益的损益 | $19,000.00 | $240,000.00 | $404,000.00 | $404,000.00 | $815,000.00 |
| 应收款 | – | – | $88,000.00 | $88,000.00 | $132,000.00 |
| -应收账款 | – | – | $88,000.00 | $88,000.00 | $132,000.00 |
| -累计折旧 | – | – | -$1.55M | -$1.55M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$31.42M | -$36.88M | -$123.34M | -$27.90M | -$30.37M |
| 持续经营经营活动现金流净额 | -$31.42M | -$36.88M | -$123.34M | -$27.90M | -$30.37M |
| 持续经营净利润 | -$43.42M | -$41.28M | -$144.74M | -$33.00M | -$34.39M |
| 折旧、折耗与摊销 | $43,000.00 | $98,000.00 | $525,000.00 | $108,000.00 | $120,000.00 |
| 其他非现金项目 | $31,000.00 | $4.05M | -$169,000.00 | -$433,000.00 | $0.00 |
| 营运资金变动 | $4.82M | -$5.26M | -$1.08M | $92,000.00 | -$1.94M |
| -预付资产变动 | -$325,000.00 | $1.43M | $3.98M | $682,000.00 | -$3.64M |
| -应付账款及应计费用变动 | $5.18M | -$6.66M | -$6.02M | -$934,000.00 | $1.06M |
| -其他流动资产变动 | $340,000.00 | $298,000.00 | $1.73M | $271,000.00 | $336,000.00 |
| -其他流动负债变动 | -$375,000.00 | -$327,000.00 | -$1.16M | $23,000.00 | -$27,000.00 |
| 投资活动现金流净额 | -$149.80M | $36.26M | $14.04M | $29.47M | $5.24M |
| 持续经营投资活动现金流净额 | -$149.80M | $36.26M | $14.04M | $29.47M | $5.24M |
| 固定资产购置及出售净额 | -$30,000.00 | $0.00 | -$138,000.00 | -$86,000.00 | -$24,000.00 |
| 投资购置及出售净额 | -$149.77M | $40.26M | $14.18M | $29.55M | $5.26M |
| 其他投资变动净额 | $0.00 | -$4.00M | – | – | – |
| 筹资活动现金流 | $1.48M | $3.22M | $257.03M | -$208,000.00 | $191.61M |
| 持续经营筹资活动现金流净额 | $1.48M | $3.22M | $257.03M | -$208,000.00 | $191.61M |
| 股票期权行使所得 | $1.97M | $7.16M | $4.08M | $376,000.00 | $2.66M |
| 其他筹资费用净额 | -$494,000.00 | -$3.94M | $252.95M | -$584,000.00 | $188.95M |
| 期末现金余额 | $50.31M | $230.12M | $227.64M | $227.64M | $226.16M |
| 现金净变动 | -$179.74M | $2.60M | $147.73M | $1.36M | $166.47M |
| 期初现金余额 | $230.12M | $227.64M | $78.84M | $226.16M | $59.54M |
| 汇率变动影响 | -$68,000.00 | -$111,000.00 | $1.07M | $118,000.00 | $151,000.00 |
| 自由现金流 | -$31.45M | -$36.88M | -$123.48M | -$27.99M | -$30.39M |
| -应收款变动 | – | – | $383,000.00 | $50,000.00 | – |
| -存货变动 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 AMLX。
登录后参与讨论。